Tace

A simplified whole-blood culture method 2, 3 ; was used in this study. Heparinized blood was diluted with 20 vol umes of Roswell Park Memorial Institute 1640 culture medium. Three-mi aliquots of the diluted blood were dis tributed to disposable polystyrene culture tubes, 16 x 125 mm, and 1 Ci of thymidine-3H 2 Ci mmole ; was added to each tube. Tubes were incubated in an upright position, at 37, or 24 hr. Cultures were set up in duplicate or tripli f cate, and radioactivity incorporated into the leukocytes was determined by liquid scintillation counting. Counting efficiency was usually 40 to 45%. Studies were performed in 33 cases in CLL, in varying disease and treatment status. The diagnosis of CLL was based on demonstration of a ; persistent elevation of the WBC count above 15, 000 cu mm, due to lymphocytosis, and b ; lymphocytic infiltration of the bone marrow. Pa tients originally diagnosed as having lymphosarcoma, who later developed a leukemic blood picture i.e., leukolymphosarcoma ; were excluded from this study. Disease status at the time of study was classified into 5 categories, as follows: 0 complete peripheral remission ; , lymphocytes 2500 cu mm; no adenopathy, hepatomegaly, or overt tissue in filtration; no anemia or thrombocytopenia unless caused by treatment ; . I, lymphocytosis 2500 cu mm ; but no other peripheral manifestations of disease. II, slight to moderate adenopathy and or splenomegaly 5 cm below costal margin. Ill, marked adenopathy and or spleno megaly 5 cm. IV, hepatomegaly and or overt tissue in filtration with leukemic cells. In addition, each patient's functional status was classified as "good, " "fair, " or "poor." In most cases, patients were followed for about 1 year after determination of thymidine3H uptake. The patients ranged in age from 40 to 82 years median, 63 years ; . There were 21 men and 12 women. The diagnosis CANCER RESEARCH VOL. 34.
The phenotype of TACE knock-out mice and that of the embryonic fibroblasts generated from these mice strongly suggest that TACE is necessary for the shedding of a subset of cell surface proteins with disparate structures and functions 6, 12, 13, ; . Given this promiscuity, it seems reasonable to conjecture that the activity of TACE is under tight control to prevent unwanted proteolysis. However, little is known about the cellular mechanisms that control the activity of TACE; furthermore, although it has been long known that ectodomain shedding is a regulated process see for example 31 it is not known how the activity of TACE is upregulated upon activation of PKC or MAP kinases, two well characterized mediators of the activation of ectodomain shedding for a recent review, see 32 Several years ago we undertook a genetic approach to characterize the shedding machinery that acts on proTGF- a. First, we isolated chemically-induced somatic cell mutants M1 and M2 cells ; defective in the activated shedding of proTGF- a and, subsequently, we found that these mutant cell lines have a gross defect in the shedding of a variety of proteins, including many substrates whose shedding is also defective in TACE cells 10-14 ; . However, the wild type phenotype of somatic cells fusions between M2 and TACE cells indicated that the defect in M2 cells affects a component other than TACE 13 ; . TACE transfected into M2 cells does not rescue the wild type phenotype, indicating that the component defective in these mutant cells is different from TACE 13 ; furthermore, no mutations can be detected in TACE from M2 cells this report ; . Therefore, the defect in M2 cells does not affect TACE, thus, the characterization of this defect provides an opportunity to study mechanisms that control the activity of TACE. Due to the current availability of polyclonal antibodies that allow the detection of endogenous TACE in CHO cells, we found that the processing of the metalloprotease is completelly blocked in M1 and M2 cells. This result apparently contradicts a previous one, since a C-teminal-tagged version of TACE was judged to be processed marginally, but to the same extent, in wild type and mutant cells 13 ; . However, several lines of evidence strongly suggest that the fate of transfected TACE is not a good indicator of that of the endogenous protein and that the apparent "processing" previously observed with transfected TACE is artifactual. Pulse-chase experiments show that prodomain processing affects to near all detectable TACE labeled after the pulse this report and 19 , while it affects only to ~10% of transfected TACE 13 ; . In addition, the electrophoretic migration of the marginal amount of TACE "processed" in transient transfections is different from that of the endogenous processed protein data not shown ; . Currently the basis for the artifactual "processing" of TACE in transient transfections are unknown, presumably they could be related to.

Faculty of Biology, Sofia University "St. Kliment Ohridski", 8 Dragan Tsankov blv, Department of cytology, histology and embryology, 1164 Sofia, Bulgaria; 2 Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-4370; 3 Institute of Biophysics, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria; 4Faculty of Biology, Sofia University "St. Kliment Ohridski", 8 Dragan Tsankov blv, Department of biochemistry, 1164 Sofia, Bulgaria e.mail for correspondence: stephanova biofac sofia.bg The halogenated hydrocarbons, such as halothane, are among the currently used anesthetics in clinics. Because of their lypophilic properties, the first effect on cellular level is expressed as direct interaction with membrane lipids, and therefore influence membrane fluidity affecting the cell surface receptors. Among the most important cell surface receptors responsible for outside-in signaling pathways are a family of glycoproteines, realizing the contact between extracellular matrix and cellular cytoskeleton. Integrin receptors are known to form clusters in so called focal adhesion complexes, along with other proteins, such as vinculin, paxillin, focal adhesion kinase and so on, which contact to F-actin stress fibers. The aim of our work was to estimate the effect of volatile anesthetic halothane on focal adhesion formation, when it is applied to lung carcinoma cells A 549 in clinically relevant concentrations. W saturated culture medium DMEM, supplemented with 10 % FBS, with halothane and achieved a final concentration of saturated solution 3.0 mM. A 549 cells were grown in 0.9, 1.5 and 2.1 mM halothane for 2 hours at 37 0 C, CO2 and humidified atmosphere. After treatment we fixed the cells with 4 % paraformaldehyde and using indirect immunofluorescense approaches, we showed distribution of F-actin, vinculin and paxillin. Our results indicated that the sub-toxic clinically relevant concentration of 0.9 mM induced disruption of focal adhesion complexes. These results were confirmed for both vinculin and paxillin, even there were no detectable damages on cell periphery and F-actin stress fibers formation. Higher concentrations of 1.5 and 2.1 mM halothane, however induced cell shrinkage and these results were consistent with our previous data, for induction of cell detachment and loss of adhesion. 1. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant 1998; 17: 703709. Marshall SE, Kramer MR, Lewiston NJ, Starnes VA, Theodore J. Selection and evaluation of recipients for heart-lung and lung transplantation. Chest 1990; 98: 1488 Smith CM. Patient selection, evaluation, and preoperative management for lung transplant candidates. Clin Chest Med 1997; 18: 183197. Mannes GP, de Boer WJ, van der Bij W, Grevink RG, Koeter GH. Three hundred patients referred for lung transplantation. Experiences of the Dutch Lung Transplantation Program. Groningen Lung Transplantation Group. Chest 1996; 109: 408413. Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant 2002; 21: 950970. Snell GI, De Hoyos A, Winton T, Maurer JR. Lung transplantation in patients over the age of 50. Transplantation 1993; 55: 562566. Leibowitz DW, Caputo AL, Shapiro GC, et al. Coronary angiography in smokers undergoing evaluation for lung transplantation: is routine use justified? J Heart Lung Transplant 1994; 13: 701703. Thaik CM, Semigran MJ, Ginns L, Wain JC, Dec GW. Evaluation of ischemic heart disease in potential lung transplant recipients. J Heart Lung Transplant 1995; 14: 257266. Hadjiliadis D, Tapson VF, Davis RD, Palmer SM. Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation. J Heart Lung Transplant 2001; 20: 13051309. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest 1996; 109: 11761183. Shane E, Papadopoulos A, Staron RB, et al. Bone loss and fracture after lung transplantation. Transplantation 1999; 68: 220227. Dodd VA, Staron RB, Papadopoulos A, et al. Bone densitometry should be included in the evaluation of. Cheap tace online Tumor imaging 8 days after the implantation, MR could show node with clear shape in some cases, which showed hypointensity on T1weighted and hyperintensity on T2-weighted Figure 3 ; . 14 days after the implantation, MR could detect lesions in all cases. Some degree of necrosis was seen in the center of the mass in 17 cases, presented as a lower intensity on T1 and T2-weighted as compared with the pathologic tissue without necrosis Figure 4 ; . One week after hepatic artery infusions, necrosis was found in all cases of control group and little change was found before and after therapy. While in TACE group, MR features were as follows: the signal in the center of lesion was asymmetrical.

A. Undergraduate Theses MSc Degree ; for state examinations after three years of study supervisors are written in brackets and tacrine. Receive a deduction in the full amount of the Buyout included in previous Contract Years ; in its final Actual Club Payroll in the Contract Year covered by that option; or B ; receive a distribution from the Competitive Balance Tax proceeds described in Section H 1 ; below in the amount of any Competitive Balance Tax paid by that Club for any Contract Year as a result of the previous inclusion of the Buyout in the Club's final Actual Club Payroll. c ; Club Option Years i ; General Rule. If a Uniform Player's Contract covers one or more seasons that are Club Option Years, the Player's Salary for the championship seasons that are Club Option Years, if exercised, shall be the total of the Base Salary and any bonuses included by operation of Section E 4 ; above. ii ; Contracts Extending Into 2007 or Beyond. This subparagraph ii ; shall apply only to a Uniform Player's Contract agreed to after September 30, 2002 that includes one or more Club Option Years that fall in the 2007 Contract Year or later. A ; Special Definitions. For the purposes of this subparagraph ii ; only, the following definitions shall apply: "Club Option Year Value" shall be the Salary attributed to a Club Option Year under subparagraph i ; above, plus any potential bonuses other than Award Bonuses ; attributable to that Year, minus any Option Buyout that relates to that Club Option Year. "Highest Guaranteed Year Value" shall be the sum of the Base Salary plus any attributed Signing Bonus, deferred compensation or annuity costs, plus any potential bonuses other than Award Bonuses ; in the Guaranteed Year of the Contract with the highest such sum; provided, however, that if the Highest Guaranteed Year Value is itself greater than 127.5% of the Average Annual Value of the Contract, then 127.5% of the Average Annual Value of the Contract shall be substituted for the Highest Guaranteed Year Value in the calculation called for by subparagraph ii ; B ; below. PO: Administer around the clock. May be administered without regard to food. Shake oral suspension well before administering. Refrigerate oral suspensions. Do not administer within 2 hr before or after antacids or iron supplements. Instruct patient to take medication around the clock at evenly spaced times and to finish the medication completely as directed, even if feeling better. Missed doses should be taken as soon as possible unless almost time for next dose; do not double doses. Instruct patient to use calibrated measuring device with liquid preparations. Advise patient that sharing this medication may be dangerous. Advise patient to report signs of superinfection furry overgrowth on the tongue, vaginal itching or discharge, loose or foul-smelling stools ; and allergy. Instruct patient to notify health care professional if fever and diarrhea develop, especially if diarrhea contains blood, mucus, or pus. Advise patient not to treat diarrhea without consulting health care professional and tamiflu. Order tace

PTPH1 interacts with TACE via its PDZ domain in the yeast two-hybrid system--The cytoplasmic domain of TACE was used as bait in a yeast two-hybrid screen of a HeLa cDNA library. In addition to identifying MAD2 38 ; , a single clone encoding amino acids 402-913 of PTPH1 was found to interact with TACE based on both nutritional selection and -galactosidase activity. This fragment of PTPH1 was not able to interact with the GAL4 DNA-binding domain alone or with a negative control protein human lamin C fused to the GAL4 DNA-binding. From prescription data in Shiffman et al.31 From the National Health Interview Survey.27 FTND, Fagerstrom test for nicotine dependence and tao. ACKNOWLEDGMENTS We thank Kimberly Winges and Dennis Lee for help with cell culture and Ramsey Asmar, Teresa Au, Anthony Ko, and Esteban Gomez for contributions to developmental work on the VG apparatus. Present address of T. Irokawa: Dept. of Respiratory & Infectious Disease, Postgraduate Div., Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan E-mail: irokawa int1.med.tohoku.ac.jp ; . GRANTS This work was supported by National Institutes of Health Grants DK-51817 and HL-60288 and by the Cystic Fibrosis Foundation. REFERENCES 1. Ballard ST, Trout L, Bebok Z, Sorscher EJ, and Crews A. CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. J Physiol Lung Cell Mol Physiol 277: L694 L699, 1999. 2. Devor DC, Singh AK, Bridges RJ, and Frizzell RA. Modulation of Cl secretion by benzimidazolones. II. Coordinate regulation of apical GCl and basolateral GK. J Physiol Lung Cell Mol Physiol 271: L785L795, 1996. 3. Devor DC, Singh AK, Frizzell RA, and Bridges RJ. Modulation of Cl secretion by benzimidazolones. I. Direct activation of a Ca2 -dependent K channel. J Physiol Lung Cell Mol Physiol 271: L775L784, 1996. AJP-Lung Cell Mol Physiol VOL. And its protein levels by immunoblotting Fig. 3H ; . Transfection with TACE siRNA, but not ADAM12 siRNA, inhibited TACE mRNA Fig. 3G ; and protein levels Fig. 3H ; and attenuated CXCL16-mediated TNF- secretion Fig. 3I ; . However, TACE inhibition or TNF- neutralization failed to modulate CXCL16-induced NF- B activation Fig. 3J ; , indicating that the effects of CXCL16 on NF- B activation are direct and are not mediated by TNF- as has been reported previously for SDF-1 21 ; . CXCL16 Induces Cell-Cell Adhesion and Cellular Proliferation--From the aforementioned studies, it is clear that CXCL16 is a strong inducer of NF- B in HASMC, and this induction of NF- B is mediated through Akt. Activation of Akt regulates survival signals induced by cytokines, chemokines, and growth factors 18 ; . Upon activation, Akt phosphorylates downstream pro-apoptotic signaling molecules such as Bad, rendering them inactive 18 ; . Furthermore, Akt activates NF- B 22 ; , and activation of NF- B plays a role in growth factor-induced cell proliferation 23 ; . Because CXCL16 activated Akt and induced Akt-dependent NF- B activation, we hypothesized that CXCL16 may promote ASMC survival and proliferation. Fig. 4A shows low levels of oligonucleosomal fragmented DNA in untreated controls, and unlike SNAP, a nitric oxide donor, CXCL16, failed to induce cell death. In addition, MTT reduction and [3H]thymidine incorporation assays indicated that CXCL16 is in fact mitogenic to ASMC Fig. 4, B and C ; . However, CXCL16 increased ASMC proliferation was more pronounced at days 5 and 7 after treatment. Platelet-derived growth factor-BB was used as a positive control and induced HASMC proliferation. Our results also demonstrated that CXCL16 induced phosphorylation of Bad at Ser112 Fig. 4D ; , indicating that CXCL16 is pro-mitogenic and not a pro-apoptotic chemokine. To verify whether CXCL16 induces HASMC proliferation via NF- B activation, we performed transient transfection assays using NF- Bp65 or IKK- siRNA expression vectors. Fig. 4E shows that transfection with p65siRNA or IKK- siRNA significantly inhibited CXCL16-mediated Bdriven luciferase activity and significantly increased oligonucleosomal fragmented DNA Fig. 4F ; . Inhibition of NF- B also significantly reduced HASMC numbers following CXCL16 addition, indicating that CXCL16 induces cell proliferation via NF- B activation Fig. 4G ; . Because cell-cell signaling plays a role in cellular proliferation, we investigated whether CXCL16 increases cell-cell adhesion. Fig. 4H shows that treatment with CXCL16 significantly increased cell-cell adhesion as seen by increased calcein acetoxymethyl ester fluorescence. Together, these results indicate that CXCL16 increases cell-cell adhesion and ASMC proliferation and tarceva. CDNA Constructs and Reagents--A FLAG-tagged full-length murine TRANCE expression vector pFLAG-TRANCE ; has been described 5 ; . hCD8-TRANCE was expressed in baculovirus and purified on an -hCD8-Sepharose column as described 1 ; . Mouse TRANCE-R fused to human IgG1 TR-Fc ; was cloned into the vector PVL1392 and expressed in baculovirus. Purification was performed by binding to a protein A-Sepharose column, eluting with glycine 0.2 M, pH 2.9 ; , and dialyzing against PBS. M2 anti-FLAG mAb was purchased from Sigma. A cDNA fragment encoding for the human TACE cytotail corresponding to amino acids 695 824 ; was cloned in frame to the coding region of GST in the pGEX-4T-1 vector Amersham Pharmacia Biotech ; . The GSTTACE cytotail fusion protein was expressed and purified from BL21 bacteria and used as an immunogen to raise rabbit polyclonal antisera as described previously 15 ; . Cell Cultures--The T cell hybridoma KMLS-8.3.5.1 5 ; was grown in S-minimal essential medium supplemented with 10% fetal bovine serum. COS-7 and 293T cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Transient Transfections--COS-7 cells were transiently transfected with pcDNA3 vector or pFLAG-TRANCE vector with LipofectAMINE Life Technologies, Inc. ; following the manufacturer's suggestions. Human 293T cells were transiently transfected with similar constructs using a standard calcium phosphate method. Pulse-Chase Analysis--COS-7 cells transiently transfected with either pcDNA3 vector or pFLAG-TRANCE were subjected to pulse-chase with 200 Ci of 35S-labeled methionine and cysteine EXPRESS, NEN Life Sciences ; as described previously 16 ; . After chasing in Opti-MEM Life Technologies, Inc. ; for different amounts of time, supernatant and lysate samples were spun at 13, 000 rpm in a Sorvall tabletop centrifuge for 15 min. Where indicated, the hydroxamate-based metalloproteaseinhibitor batimastat BB-94 ; 17 ; , the serine protease inhibitors leupeptin Sigma ; , N-tosyl-L-phenylalanine chloromethyl ketone TPCK, Sigma ; , soybean trypsin inhibitor STI, Sigma ; , 4- 2-aminoethyl ; benzenesulfonylfluoride hydrochloride Pefabloc SC, Roche Molecular Biochemicals ; , the cysteine protease inhibitor L-trans-epoxysuccinylleucylamide- 4-guanidino ; butane E-64, Sigma ; , or the aspartate protease inhibitor pepstatin Sigma ; were included in the chase medium in the presence or absence of TPA 50 ng ml ; KMLS-8.3.5.1 cells were labeled overnight with 50 Ci of EXPRESS label and then stimulated for 3 h in the presence of ionomycin 500 ng ml ; and TPA 50 ng ml ; The cleared cell lysates were immunoprecipitated with the M2 anti-Flag mAb or TR-Fc as indicated ; , and protein G beads, and the cleared supernatants were immunoprecipitated with the TR-Fc and protein A beads. The immunoprecipitated material was recovered by boiling in sample loading buffer, and separated by SDS-PAGE. Gels were fixed in 50% methanol, 10% acetic acid and incubated in 1 M salicylic acid for 15 min prior to drying and exposure to autoradiography film Kodak XAR ; . Western Blot Analysis--Approximately 500 g of cleared lysates from COS-7, 293T, and THP-1 cells were incubated with concanavalin ASepharose Amersham Pharmacia Biotech ; . Bound glycoproteins were eluted with sample loading buffer and boiling at 95 C for 5 min. Western analysis was performed following SDS-PAGE as described previously 18 ; . In Vitro Cleavage of Full-length TRANCE, hCD8-TRANCE, and Nterminal Sequence Analysis--To generate full-length TRANCE, COS-7 cells transiently transfected with FLAG-TRANCE were pulse-labeled and then chased for 3 h as described above. FLAG-TRANCE was immunoprecipitated and washed three times in lysis buffer without protease inhibitor, followed by one wash in PBS. After incubation overnight at 37 C with recombinant TACE 10 ; 2.5 g ml ; or MMP-1 19 ; 0.1 g ml ; , the samples were eluted from the beads by boiling in sample loading buffer and subjected to SDS-PAGE. Proteolysis of hCD8.
DISCUSSION M1 and M2 cell lines have provided a wealth of information on the process of ectodomain shedding 44, 57, 58, ; . An especially noteworthy observation made from these mutants is that numerous transmembrane proteins depend on metalloprotease activity for shedding 58 ; . Nevertheless, the molecular defects in these cells remain unknown. In this study we have demonstrated that inactivating mutations in TACE are the cause of ectodomain shedding deficiencies in both M1 and M2 cells. Accordingly, we identified TACE mutants from these two cell lines, and further showed that the mutants are enzymatically inactive in the cellular context using TNF- and TGF- release as readouts. Thus, like EC2 cells, the M1 and M2 cell lines should be valuable reagents for identifying additional TACE substrates and for structuralfunctional analyses of TACE. M1 and M2 cell lines were isolated from independently mutagenized CHOT stocks 58, 60 ; . The TACE mutations identified from these cell lines confirm that they are indeed distinct clones. Thus, M1 carries only one expressible TACE allele with the M435I mutation, whereas M2 contains two mutated alleles, encoding the C225Y and C600Y TACE proteins, respectively. The M435I M1mp ; mutant could not restore ectodomain shedding in M2 cells; the C225Y M2mp ; and C600Y M2crd ; variants also failed to recover shedding in M1 cells. These data are consistent with a previous study, which found no complementation between M1 and M2 cell lines upon cell fusion 58 ; . However, our data also contrast with several published findings which include a lack of TNF- shedding in TACE-transfected M2 cells 59 ; . Since we reproducibly restored shedding of both TNF- and TGF- in M1 and M2 by transfection with expression plasmids for wild type human, mouse and hamster TACE, the reason for this discrepancy remains unknown and targretin.
Sex. According to participants, due to the strong traditions, women in Georgia are better protected from HIV fewer sexual contacts, fewer cases of drug use ; than women in western countries. In addition, participants noted that in patriarchal societies there is less confidence in medicine, people conceal their problems, and are afraid of condemnation. This could also be related to the HIV and AIDS issues. In regards to safer sex, the group noted that people in Tbilisi are better informed about protection means and use them more often, than people in the province. However, some problems are also observed.
To ensure that the subjects did not actively move the arm during trials, EMGs of the biceps and triceps muscles of the tested arm were recorded via silver chloride surface electrodes gain 2500, bandwidth 30500 Hz, sampling rate 200 Hz ; . EMG recordings were monitored online by one of the investigators. Any trial exhibiting EMG activity was excluded from further analysis and repeated and tarka. Page 607 The WHO classification scheme, although still reliant on histologic findings, also attempts to incorporate all pertinent data, such as clinical presentation, immunophenotype, and cytogenetic and molecular data. Page 610 This trial helped to establish four cycles of ABVD followed by involved-field radiation therapy as the standard treatment for stage I or stage II Hodgkin lymphoma. Page 614 If the MALT lymphoma fails to respond to antibiotic therapy, involved-field radiation therapy to the stomach and perigastric lymph nodes or chemotherapy is recommended. Page 616 R-CHOP chemotherapy is establishing itself as a new standard regimen for treating patients with diffuse large B-cell lymphoma. Page 619 In general, it appears that combined-modality therapy achieves better disease-free and overall survival rates than does chemotherapy alone. However, there has been less CNS toxicity in patients treated with chemotherapy alone 37.
Charge amounts that suggest a generic might have been dispensed when a brand name ndc was submitted on the claim and taxol. Edical Ctr. Inst. for Cancer Res.
The first description of angioedema in the Western medical literature is attributed to Robert Graves' 1843 Clinical Lectures. As reported by Major, 1 Graves wrote in his 1888 edition: "Sometimes the lips inside of the mouth, palate, and uvula are attacked, giving rise to a very considerable inconvenience. Were such tumors to occur in the neighborhood of the glottis, I need not say that they would be pregnant with danger of no ordinary character." Today we regard angioedema as an immunologically mediated, anatomically limited, nonpitting edema that up to 10% of the American population may experience during their lifetime. 2 Angioedema is distinguished from the more common urticaria by the location of the edema and by the accompanying symptoms and taxotere. Figure 5. Changes in chromaffin granule transmitter concentrations in plasma after intravenous combination chemotherapy for malignant pheochromocytoma, stratified by response to chemotherapy: n 5 patients with response to chemotherapy versus n 4 patients with no response to chemotherapy. Post chemotherapy nadir values were analyzed in 4 nonresponders, samples obtained at 6.6 1.1 [range, 4 to 9] months after initiation of treatment; in 5 responders, samples obtained at 13.2 2.5 [range, 6.5 to 22] months after initiation of treatment ; . Normal ranges see Table 1 ; : chromogranin A, 48.0 3.0 ng mL; norepinephrine, 200 7.8 pg mL; epinephrine, 18.0 1.5 pg mL. A, Chromogranin A. B, Norepinephrine. C, Epinephrine. To convert chromogranin A from ng mL to multiply by 1.0. To convert epinephrine from pg mL to pmol L, multiply by 5.458. To convert norepinephrine from pg mL to nmol L, multiply by 0.005911.

From January 1993 to June 1998, 473 patients with large HCC who were eligible for this study were treated at the Tumor Hospital of Sun Yat-sen University of Medical Sciences. The a eligibility criteria for entering this study were as follows: diagnosis of HCC was established on the basis of the patient's high serum alpha-fetoprotein AFP ; value, findings obtained at computed tomography CT ; scan and clinical manifestations; the largest diameter of the tumor exceeded 5 cm; there was no evidence of portal trunk occlusion by thrombosis, extrahepatic metastasis, jaundice or ascites; during the TACE procedure the catheter was successfully inserted into the target artery selectively as proved by angiography. We excluded patients who had Child's C grade liver function or ICG-R15 indocyanine green retention rate in 15 min ; 30%. All patients were randomly divided into two treatment groups. In Group A, 216 patients received more than 20mL of iodized oil in the first TACE, and in Group B, 257 patients received 5-15mL. Table 3. Clinical effects of THAL-PRED on 21 patients with MMM Demographics Patient 1 2 3 Age 72 55 78 Sex F M M MMM type AMM PPMM AMM AMM AMM PTMM AMM AMM AMM AMM PPMM AMM AMM AMM MMM AMM AMM AMM PTMM PPMM PTMM Cell 30 95 70 Karyotype Normal 18p ; Normal Normal t 1; 10 ; t 3; Normal 21 ; 13q ; t 1; 7 ; 20q ; Normal 20q ; Normal Normal Complex NA Normal 20q ; Normal Normal Hb start 9.7 * 12.9 8.4 9.6 * 7.9 7.2 * 9 * 7.5 * 11 9.8 10.9 * 8.3 * 9 8.3 8.8 * 9.4 * 10.7 8.3 12 * Hb max 10.7 * 15.2 11.3 10.8 * 9.8 9.6 * 11.1 11.5 13 * 10.6 11 11.2 * 11.7 10.7 13.4 * THAL-PRED effects PLT start 24 303 154 PLT max 35 477 389 Spleen start 9 15 22 Spleen min 9 13 CD34 at start 851 24 32 CD34 at 3 mo 1288 17 41 NA 100 3 13 Anemia N Y Y Responses Platelet N NA NA Spleen N N Y and tacrine.